{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T01:10:18Z","timestamp":1791681018617,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,3]],"date-time":"2013-02-03T00:00:00Z","timestamp":1359849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/nm.3078","type":"journal-article","created":{"date-parts":[[2013,2,3]],"date-time":"2013-02-03T13:32:15Z","timestamp":1359898335000},"page":"368-371","source":"Crossref","is-referenced-by-count":312,"title":["Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL"],"prefix":"10.1038","volume":"19","author":[{"given":"Gannie","family":"Tzoneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Perez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khiabanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tosello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Allegretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Paietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Racevskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Paganin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Kirschner-Schwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Palomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,3]]},"reference":[{"key":"BFnm3078_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/leu.2009.257","volume":"24","author":"A M\u00f6ricke","year":"2010","unstructured":"M\u00f6ricke, A. et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24, 265\u2013284 (2010).","journal-title":"Leukemia"},{"key":"BFnm3078_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/leu.2009.261","volume":"24","author":"WL Salzer","year":"2010","unstructured":"Salzer, W.L. et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984\u20132001: a report from the children\u2032s oncology group. Leukemia 24, 355\u2013370 (2010).","journal-title":"Leukemia"},{"key":"BFnm3078_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1056\/NEJM199007053230104","volume":"323","author":"G Koren","year":"1990","unstructured":"Koren, G. et al. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N. Engl. J. Med. 323, 17\u201321 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3078_CR4","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817.409k04_2817_2823","volume":"93","author":"MV Relling","year":"1999","unstructured":"Relling, M.V., Hancock, M.L., Boyett, J.M., Pui, C.H. & Evans, W.E. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93, 2817\u20132823 (1999).","journal-title":"Blood"},{"key":"BFnm3078_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui, C.H. & Evans, W.E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166\u2013178 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3078_CR6","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","volume":"28","author":"G Tallen","year":"2010","unstructured":"Tallen, G. et al. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J. Clin. Oncol. 28, 2339\u20132347 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3078_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"PS Gaynon","year":"1998","unstructured":"Gaynon, P.S. et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse\u2014the Children\u2032s Cancer Group Experience. Cancer 82, 1387\u20131395 (1998).","journal-title":"Cancer"},{"key":"BFnm3078_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood-2008-12-192039","volume":"114","author":"V Tosello","year":"2009","unstructured":"Tosello, V. et al. WT1 mutations in T-ALL. Blood 114, 1038\u20131045 (2009).","journal-title":"Blood"},{"key":"BFnm3078_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.1164266","volume":"322","author":"CG Mullighan","year":"2008","unstructured":"Mullighan, C.G. et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377\u20131380 (2008).","journal-title":"Science"},{"key":"BFnm3078_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1084\/jem.20110105","volume":"208","author":"E Clappier","year":"2011","unstructured":"Clappier, E. et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J. Exp. Med. 208, 653\u2013661 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm3078_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","volume":"204","author":"BJ Thompson","year":"2007","unstructured":"Thompson, B.J. et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 204, 1825\u20131835 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm3078_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157\u2013163 (2012).","journal-title":"Nature"},{"key":"BFnm3078_CR13","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1074\/jbc.M413200200","volume":"280","author":"A Jalota","year":"2005","unstructured":"Jalota, A. et al. Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine\u2013rich motif. J. Biol. Chem. 280, 16019\u201316029 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm3078_CR14","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1128\/MCB.23.23.8902-8912.2003","volume":"23","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 23, 8902\u20138912 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm3078_CR15","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","volume":"29","author":"J Hof","year":"2011","unstructured":"Hof, J. et al. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 29, 3185\u20133193 (2011).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3078_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1172\/JCI6863","volume":"104","author":"F Bunz","year":"1999","unstructured":"Bunz, F. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263\u2013269 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm3078_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1182\/blood.V75.5.1163.1163","volume":"75","author":"M L\u00fcbbert","year":"1990","unstructured":"L\u00fcbbert, M. et al. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 75, 1163\u20131169 (1990).","journal-title":"Blood"},{"key":"BFnm3078_CR18","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe, P. et al. ETV6 mutations in early immature human T cell leukemias. J. Exp. Med. 208, 2571\u20132579 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm3078_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith, E. et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 10, 147\u2013156 (2009).","journal-title":"Lancet Oncol."},{"key":"BFnm3078_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1006\/bbrc.1994.2752","volume":"205","author":"J Oka","year":"1994","unstructured":"Oka, J., Matsumoto, A., Hosokawa, Y. & Inoue, S. Molecular cloning of human cytosolic purine 5\u2032-nucleotidase. Biochem. Biophys. Res. Commun. 205, 917\u2013922 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3078_CR21","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1016\/S0021-9258(18)37348-4","volume":"263","author":"J Spycha\u0142a","year":"1988","unstructured":"Spycha\u0142a, J., Madrid-Marina, V. & Fox, I.H. High Km soluble 5\u2032-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. J. Biol. Chem. 263, 18759\u201318765 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFnm3078_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cccn.2005.05.006","volume":"361","author":"C Brouwer","year":"2005","unstructured":"Brouwer, C. et al. Role of 5\u2032-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment. Clin. Chim. Acta 361, 95\u2013103 (2005).","journal-title":"Clin. Chim. Acta"},{"key":"BFnm3078_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.01.003","volume":"107","author":"SA Hunsucker","year":"2005","unstructured":"Hunsucker, S.A., Mitchell, B.S. & Spychala, J. The 5\u2032-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther. 107, 1\u201330 (2005).","journal-title":"Pharmacol. Ther."},{"key":"BFnm3078_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/1042819031000077142","volume":"44","author":"CM Galmarini","year":"2003","unstructured":"Galmarini, C.M., Jordheim, L. & Dumontet, C. Role of IMP-selective 5\u2032-nucleotidase (cN-II) in hematological malignancies. Leuk. Lymphoma 44, 1105\u20131111 (2003).","journal-title":"Leuk. Lymphoma"},{"key":"BFnm3078_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0145-2126(92)90033-4","volume":"16","author":"R Pieters","year":"1992","unstructured":"Pieters, R. et al. Relation of 5\u2032-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. Leuk. Res. 16, 873\u2013880 (1992).","journal-title":"Leuk. Res."},{"key":"BFnm3078_CR26","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1111\/j.1432-1033.2004.04457.x","volume":"271","author":"S Allegrini","year":"2004","unstructured":"Allegrini, S. et al. Mechanistic studies on bovine cytosolic 5\u2032-nucleotidase II, an enzyme belonging to the HAD superfamily. Eur. J. Biochem. 271, 4881\u20134891 (2004).","journal-title":"Eur. J. Biochem."},{"key":"BFnm3078_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/00003495-200868040-00004","volume":"68","author":"M Sanford","year":"2008","unstructured":"Sanford, M. & Lyseng-Williamson, K.A. Nelarabine. Drugs 68, 439\u2013447 (2008).","journal-title":"Drugs"},{"key":"BFnm3078_CR28","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","volume":"23","author":"SL Berg","year":"2005","unstructured":"Berg, S.L. et al. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children\u2032s Oncology Group. J. Clin. Oncol. 23, 3376\u20133382 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3078_CR29","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1182\/blood-2011-01-329441","volume":"118","author":"N G\u00f6kbuget","year":"2011","unstructured":"G\u00f6kbuget, N. et al. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia\/lymphoma offers curative option with subsequent stem cell transplantation. Blood 118, 3504\u20133511 (2011).","journal-title":"Blood"},{"key":"BFnm3078_CR30","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","volume":"109","author":"DJ DeAngelo","year":"2007","unstructured":"DeAngelo, D.J. et al. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood 109, 5136\u20135142 (2007).","journal-title":"Blood"},{"key":"BFnm3078_CR31","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1200\/JCO.2011.38.9924","volume":"30","author":"S Bhatia","year":"2012","unstructured":"Bhatia, S. et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children\u2032s oncology group. J. Clin. Oncol. 30, 2094\u20132101 (2012).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3078_CR32","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci, E. et al. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 364, 2305\u20132315 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3078_CR33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830\u2013837 (2011).","journal-title":"Nat. Genet."},{"key":"BFnm3078_CR34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E.F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFnm3078_CR35","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S.F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"BFnm3078_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725\u2013738 (2010).","journal-title":"Nat. Protoc."},{"key":"BFnm3078_CR37","doi-asserted-by":"publisher","first-page":"W215","DOI":"10.1093\/nar\/gkr363","volume":"39","author":"CL Worth","year":"2011","unstructured":"Worth, C.L., Preissner, R. & Blundell, T.L. SDM\u2014a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 39, W215\u2013W222 (2011).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3078","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:37:47Z","timestamp":1684435067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFnm3078"],"URL":"https:\/\/doi.org\/10.1038\/nm.3078","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718180326.793487028","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,3]]}}}